Needham Keeps Their Hold Rating on Steris (STE)

In a report released today, Michael Matson from Needham maintained a Hold rating on Steris (STEResearch Report). The company’s shares closed yesterday at $176.76.

Matson covers the Healthcare sector, focusing on stocks such as Steris, Teleflex, and Penumbra. According to TipRanks, Matson has an average return of 1.2% and a 45.17% success rate on recommended stocks.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Steris with a $240.00 average price target.

See today’s best-performing stocks on TipRanks >>

STE market cap is currently $17.68B and has a P/E ratio of 47.25.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.

Read More on STE:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More